Table 1.
Baseline characteristics by intervention arm (iTAB vs. SoC)
| iTAB (n=58) | SoC (n=61) | p | |
|---|---|---|---|
|
| |||
| Proportion male sex, % | 100% | 100% | - |
| Age, median (IQR) | 32.5 (28.0 –34.6) | 32.0 (28.0–35.2) | .69 |
| Education [some college or more], n (%) | 54 (93.1%) | 59 (96.7%) | .43 |
| Hispanic ethnicity, n (%) | 18 (31.6%) | 14 (23.3%) | .30 |
| Race | .70 | ||
| White, n (%) | 44 (80.0%) | 44 (74.6%) | |
| African American, n (%) | 6 (10.9%) | 11 (18.6%) | |
| Asian, n (%) | 3 (5.45%) | 2 (3.39%) | |
| Other/Unknown, n (%) | 2 (3.64%) | 2 (3.39%) | |
| Employed, n (%) | 20 (35.1%) | 7 (11.5%) | .004 |
| Income [≥$2,000/month], n (%) | 32 (68.1%) | 44 (77.2%) | .38 |
| Relationship status [single], n (%) | 27 (65.9%) | 31 (67.4%) | 1.00 |
| Sexual desire total, median (IQR) | 16.0 (12.0, 15.3) | 15.0 (11.0, 14.9) | 0.58 |
| Median DAST-10 (IQR) | 3 (3–5) | 3 (2–4.5) | .11 |
| Sexual Risk Scale | 76 (13) | 74.7 (13.6) | .58 |
| HIV Knowledgea, median (IQR) | 5.50 (3.00–5.55) | 3.00 (2.00–3.62) | 0.001 |
| PHQ9 total, median (IQR) | 6.00 (2.00–6.16) | 5.00 (2.00–5.44) | 0.38 |
| Cocaine use (yes), n (%) | 24 (41.4%) | 35 (57.4%) | 0.100 |
| Meth use (yes), n (%) | 35 (60.3%) | 27 (44.3%) | 0.099 |
| Other amphetamine use (yes), n (%) | 18 (31.0%) | 15 (24.6%) | 0.54 |
Notes:
a
square-root transformation prior to comparison analysis
DAST-10 = Drug Abuse Screening Test-10 (self-reported screen of drug use); PHQ9 = Patient Health Questionnaire-9 (depression severity measure); Sexually Transmitted Infections screened: chlamydia, gonorrhea, syphilis.
At week 12, eight participants were lost to follow up (iTAB lost n=5, SoC lost n=3). By week 48, 29 participants were lost to follow up (iTAB lost n=14, SoC lost n=15).